HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Cited by (523)

Items 101–200 of 523

  1. The neglected significance of “antioxidative stress”
    Poljsak, B., Milisav, I. · 2012 · Oxidative Medicine and Cellular Longevity
  2. On the armament and appearances of human myeloid-derived suppressor cells
    Isabel C. Poschke, Rolf W. Kiessling · 2012 · Clinical Immunology
  3. Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic
    Amit Grover, Emilio Sanseviero, Elina Timosenko, Dmitry I. Gabrilovich · 2021 · Cancer Discovery
  4. Lactate as a Signaling Molecule That Regulates Exercise-Induced Adaptations
    Nalbandian, Minas, Takeda, Masaki · 2016 · Biology
  5. Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
    Ivana Jochmanová, Chunzhang Yang, Zhengping Zhuang, Karel Pacák · 2013 · JNCI Journal of the National Cancer Institute
  6. Hypoxia‐mediated biological control
    Jessica M. Cassavaugh, Karen M. Lounsbury · 2010 · Journal of Cellular Biochemistry
  7. Inhibition of Nonsense-Mediated RNA Decay by the Tumor Microenvironment Promotes Tumorigenesis
    Ding Wang, Jiří Zavadil, Leenus Martin, Fabio Parisi, Eugene Friedman, David E. Levy, Heather P. Harding, David Ron, Lawrence B. Gardner · 2011 · Molecular and Cellular Biology
  8. Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations
    Elżbieta Pawłowska, Joanna Szczepańska, Janusz Błasiak · 2019 · Oxidative Medicine and Cellular Longevity
  9. Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
    Davinder Pal Singh, Rohit Arora, Pardeep Kaur, Balbir Singh, Rahul Mannan, Saroj Arora · 2017 · Cell & Bioscience
  10. Roles of reactive oxygen species in inflammation and cancer
    Yunfei Yu, Shengzhuo Liu, Luchen Yang, Pan Song, Zhenghuan Liu, Xiaoyang Liu, Xin Yan, Qiang Dong · 2024 · MedComm
  11. Ascorbate as a co-factor for Fe- and 2-oxoglutarate dependent dioxygenases: Physiological activity in tumor growth and progression
    Kuiper, Caroline, Vissers, Margreet C. M. · 2014 · Frontiers in Oncology
  12. Oxidative Stress Activates SIRT2 to Deacetylate and Stimulate Phosphoglycerate Mutase
    Yanping Xu, Fulong Li, Lei Lv, Tingting Li, Xin Zhou, Chu‐Xia Deng, Kun‐Liang Guan, Qun‐Ying Lei, Yue Xiong · 2014 · Cancer Research
  13. Mitochondria, cholesterol and cancer cell metabolism
    Vicent Ribas, Carmen García‐Ruiz, José Carlos Fernández-Checa · 2016 · Clinical and Translational Medicine
  14. The sodium-dependent ascorbic acid transporter family SLC23
    Bürzle, Marc, Suzuki, Yoshiro, Ackermann, Daniel, Miyazaki, Hiroki, Maeda, Nobuyo, Clémençon, Benjamin, Burrier, Robert, Hediger, Matthias A. · 2013 · Molecular Aspects of Medicine
  15. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics
    Heli J. Lehtonen · 2011 · Familial Cancer
  16. Microenvironment and Radiation Therapy
    Michio Yoshimura, Satoshi Itasaka, Hiroshi Harada, Masahiro Hiraoka · 2012 · BioMed Research International
  17. Multiscale models of angiogenesis
    Amina Ann Qutub, Feilim Mac Gabhann, Emmanouil D. Karagiannis, Prakash Vempati, Aleksander S. Popel · 2009 · IEEE Engineering in Medicine and Biology Magazine
  18. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells
    Giuseppina Comito, Maura Calvani, Elisa Giannoni, Francesca Bianchini, Lido Calorini, Eugenio Torre, Cristina Migliore, Silvia Giordano, Paola Chiarugi · 2011 · Free Radical Biology and Medicine
  19. Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1α during Hypoxia in Human Cancer Cells
    Isabelle Ader, Leyre Brizuela, Pierre Bouquerel, Bernard A. Malavaud, Olivier Cuvillier · 2008 · Cancer Research
  20. Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status
    Peishan Li, Ming Lü, Jiayuan Shi, Li Hua, Zheng Gong, Qing Li, Leonard D. Shultz, Guangwen Ren · 2020 · Nature Communications
  21. Redox control in cancer development and progression
    Valeska Helfinger, Katrin Schröder · 2018 · Molecular Aspects of Medicine
  22. Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
    Rachel Shi, Chengheng Liao, Qing Hua Zhang · 2021 · Cells
  23. Hypoxia‐inducible factor 1 and cancer pathogenesis
    Gregg L. Semenza · 2008 · IUBMB Life
  24. Mitochondrial respiration protects against oxygen-associated DNA damage
    Ho Joong Sung, Wenzhe Ma, Pingyuan Wang, James Hynes, Tomás C. O’Riordan, Christian A. Combs, John Philip McCoy, Fred Bunz, Ju‐Gyeong Kang, Paul M. Hwang · 2010 · Nature Communications
  25. Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
    Megan R. Doe, Janice M. Ascano, Mandeep Kaur, Michael D. Cole · 2011 · Cancer Research
  26. Human Genetic Variation Influences Vitamin C Homeostasis by Altering Vitamin C Transport and Antioxidant Enzyme Function
    Michels, Alexander J., Hagen, Tory M., Frei, Balz · 2013 · Annual Review of Nutrition
  27. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells
    Dongyun Shi, Feizhou Xie, Chao Zhai, Jeremy S Stern, Yang Liu, Shanlin Liu · 2009 · Molecular Cancer
  28. The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context
    Faliang Xing, Qiangsheng Hu, Yi Qin, Jin Xu, Bo Zhang, Xianjun Yu, Wei Wang · 2022 · Frontiers in Oncology
  29. Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer
    Kuiper, Caroline, Molenaar, Ilona G.M., Dachs, Gabi U., Currie, Margaret J., Sykes, Peter H., Vissers, Margreet C.M. · 2010 · Cancer Research
  30. Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
    Michela Guglielmotto · 2010 · Frontiers in Aging Neuroscience
  31. Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
    Carr, Anitra C., Cook, John · 2018 · Frontiers in Physiology
  32. Mitochondria in cancer: at the crossroads of life and death
    Vanessa C. Fogg, Nathan James Lanning, Jeffrey P. MacKeigan · 2011 · 癌症:英文版
  33. The Interplay Between MYC and HIF in the Warburg Effect
    Chi Van Dang · 2008 · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings
  34. ‘Reverse Warburg effect’ of cancer‑associated fibroblasts (Review)
    Lin Liang, Wentao Li, Xin Li, Xi Jin, Qianjin Liao, Yanling Li, Yanhong Zhou · 2022 · International Journal of Oncology
  35. The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
    Sally K. Martin, Peter Diamond, Stan Gronthos, Daniel J. Peet, Andrew C.W. Zannettino · 2011 · Leukemia
  36. Mitochondria as targets for chemotherapy
    Vladimir G. Gogvadze, Sten Orrenius, Boris Zhivotovsky · 2009 · APOPTOSIS
  37. Metabolic reprogramming of the tumor
    Leonardo M. R. Ferreira, Aline Hébrant, J.E. Dumont · 2012 · Oncogene
  38. c-MYC-Induced Genomic Instability
    Ra Kuzyk, Sabine Mai · 2014 · Cold Spring Harbor Perspectives in Medicine
  39. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
    Daniel A. Tennant, Christian Frezza, Elaine D. MacKenzie, Quang‐Dé Nguyen, Liang Zheng, Mary A. Selak, Darren L. Roberts, Caroline Dive, Dave G. Watson, Eric Ofori Aboagye et al. · 2009 · Oncogene
  40. Src redox regulation: Again in the front line
    Elisa Giannoni, Maria Letizia Taddei, Paola Chiarugi · 2010 · Free Radical Biology and Medicine
  41. Decoding Antioxidant and Antibacterial Potentials of Malaysian Green Seaweeds: Caulerpa racemosa and Caulerpa lentillifera
    W.S.P. Yap, Vangene Tay, Sie-Hui Tan, Yoon‐Yen Yow, Jactty Chew · 2019 · Antibiotics
  42. Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?
    Justyna Zińczuk, Mateusz Maciejczyk, Konrad Piotr Zaręba, Wioletta Romaniuk, Adam Markowski, Bogusław Kędra, Anna Zalewska, Anna Pryczynicz, Joanna Matowicka-Karna, Katarzyna Guzińska-Ustymowicz · 2019 · Biomolecules
  43. Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo
    Lavinia Nardinocchi, Valentina Pantisano, Rosa Puca, Manuela Porru, Aurora Aiello, Annalisa Grasselli, Carlo Leonetti, Michal Safran, Gideon Rechavi, David Givol et al. · 2010 · PLoS ONE
  44. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response
    Kuiper, Caroline, Dachs, Gabi U., Currie, Margaret J., Vissers, Margreet C.M. · 2014 · Free Radical Biology and Medicine
  45. Oxidative Stress in Cancer Therapy: Friend or Enemy?
    Maria Azmanova, Anaïs Pitto‐Barry · 2022 · ChemBioChem
  46. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer
    De Chen, Bianli Dang, Jinzhou Huang, Min Chen, Di Wu, Manli Xu, Rong Li, Guang‐Rong Yan · 2015 · Oncotarget
  47. Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
    Jason Alan Chesney, Robert A. Mitchell, Kavitha Yaddanapudi · 2017 · Journal of Leukocyte Biology
  48. The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1α (HIF-1α) in Breast Cancer Cells and Cardiomyocytes
    Anna Grazia Recchia, Ernestina Marianna De Francesco, Adele Vivacqua, Diego Sisci, Maria Luisa Panno, Sebastiano Andò, Marcello Maggiolini · 2011 · Journal of Biological Chemistry
  49. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities
    Ines Batinic̈‐Haberle, Ivan Spasojević, Hubert Ming Tse, Artak G. Tovmasyan, Zrinka Rajić, Daret K. St. Clair, Željko Vujašković, Mark W. Dewhirst, Jon D. Piganelli · 2010 · Amino Acids
  50. Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
    Ian Robey, Renu M. Stephen, Kathy S. Brown, Brenda K. Baggett, Robert A. Gatenby, Robert J. Gillies · 2008 · Neoplasia
  51. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging
    Omran Abu Aboud, Samy L. Habib, Josephine F. Trott, Benjamin J. Stewart, Sitai Liang, Abhijit J. Chaudhari, J. Sutcliffe-Goulden, Robert H. Weiss · 2017 · Cancer Research
  52. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
    Tu Anh Nguyen, Brian James Kirsch, Ryoichi Asaka, Karim Nabi, Addison Quinones, Jessica Tan, Marjorie Justine Antonio, Felipe Camelo, Ting Li, Stephanie A. Nguyen et al. · 2019 · Cell Reports
  53. Estrogen-related receptors are targetable ROS sensors
    Mathieu Vernier, Catherine R. Dufour, Shawn McGuirk, Charlotte Scholtes, Xiaojing Li, Guillaume Bourmeau, Hellen Kuasne, Morag Park, Julie St‐Pierre, Étienne Audet‐Walsh et al. · 2020 · Genes & Development
  54. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma
    Ma, Qi, Cavallin, Lucas E., Yan, Bin, Zhu, Shoukang, Duran, Elda Margarita, Wang, Huili, Hale, Laura P., Dong, Chunming, Cesarman, Ethel, Mesri, Enrique A. et al. · 2009 · Proceedings of the National Academy of Sciences
  55. Locally Deployable Nanofiber Patch for Sequential Drug Delivery in Treatment of Primary and Advanced Orthotopic Hepatomas
    Jiannan Li, Weiguo Xu, Di Li, Tongjun Liu, Yu Shrike Zhang, Jianxun Ding, Xuesi Chen · 2018 · ACS Nano
  56. The controversial place of vitamin C in cancer treatment
    Julien Verrax, Pedro Buc Calderón · 2008 · Biochemical Pharmacology
  57. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP5+, via suppression of oxidative stress in a mouse model of breast tumor
    Zahid N. Rabbani, Ivan Spasojević, Xiuwu Zhang, Benjamin J. Moeller, Sinisa Haberle, Jeannette M. Vasquez-Vivar, Mark W. Dewhirst, Željko Vujašković, Ines Batinic̈‐Haberle · 2009 · Free Radical Biology and Medicine
  58. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways
    Jianfei Qi, Koh Nakayama, Supriya Gaitonde, James Steven Goydos, Stan Krajewski, Alexey M. Eroshkin, Dafna Bar‐Sagi, David D.L. Bowtell, Ze’ev A. Ronai · 2008 · Proceedings of the National Academy of Sciences
  59. Nutritional Countermeasures Targeting Reactive Oxygen Species in Cancer: From Mechanisms to Biomarkers and Clinical Evidence
    Anatoly Samoylenko, Jubayer A. Hossain, Daniela Mennerich, Sakari Kellokumpu, Jukka Kalervo Hiltunen, Thomas Kietzmann · 2013 · Antioxidants and Redox Signaling
  60. Myeloid‐derived suppressor cells as effectors of immune suppression in cancer
    Athalia Rachel Pyzer, Leandra Cole, Jacalyn M. Rosenblatt, David Avigan · 2016 · International Journal of Cancer
  61. The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
    Stéphanie A. Castaldo, Joana Raquel Freitas, Nadine Vasconcelos Conchinha, Patrícia A. Madureira · 2015 · Oxidative Medicine and Cellular Longevity
  62. Myeloid Suppressor Cells and Immune Modulation in Lung Cancer
    Minu K. Srivastava, Åsa Andersson, Li Xin Zhu, Marni E. Harris‐White, Jay M. Lee, Steven M. Dubinett, Sherven P. Sharma · 2012 · Immunotherapy
  63. Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
    Alia Ghoneum, Ammar Yasser Abdulfattah, Bailey Warren, Junjun Shu, Neveen A. Said · 2020 · International Journal of Molecular Sciences
  64. Progress toward Overcoming Hypoxia-Induced Resistance to Solid Tumor Therapy
    Reginato, Mauricio, Karakashev, Sergey · 2015 · Cancer Management and Research
  65. Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression
    Jun Yang, Oliver D. Staples, Luke W. Thomas, Thomas Briston, Mathew P. Robson, Evon Poon, Maria L. Simões, Ethaar El‐Emir, Francesca Meteora Buffa, Afshan Ahmed et al. · 2012 · Journal of Clinical Investigation
  66. Facilitating replication under stress: an oncogenic function of MYC?
    Steffi Herold, Barbara Herkert, Martin Eilers · 2009 · Nature reviews. Cancer
  67. Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives
    Ye Zhang, Yilin Fang, Hong Liang, Heng‐Shan Wang, Kun Hu, Xianxian Liu, Xianghui Yi, Yan Peng · 2012 · Bioorganic & Medicinal Chemistry Letters
  68. Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)
    Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, Federica Sotgia, Michael P. Lisanti · 2017 · Oncotarget
  69. Targeting Mitochondrial Oxidative Metabolism in Melanoma Causes Metabolic Compensation through Glucose and Glutamine Utilization
    Ji-Hong Lim, Chi Luo, Francisca Vazquez, Pere Puigserver · 2014 · Cancer Research
  70. Paradoxical action of reactive oxygen species in creation and therapy of cancer
    Sina Kardeh, Soheil Ashkani‐Esfahani, Ali Mohammad Alizadeh · 2014 · European Journal of Pharmacology
  71. Molecular Crosstalk Between MYC and HIF in Cancer
    Yanping Li, Xiao‐Xin Sun, David Z. Qian, Mu‐Shui Dai · 2020 · Frontiers in Cell and Developmental Biology
  72. Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species
    Maura Calvani, Giuseppina Comito, Elisa Giannoni, Paola Chiarugi · 2012 · PLoS ONE
  73. Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
    Anja Frömberg, Daniela Gutsch, Daniel Schulze, Claudia Vollbracht, Gabriele Weiß, Frank Czubayko, Achim Michael Aigner · 2010 · Cancer Chemotherapy and Pharmacology
  74. Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation
    Domenico Mastrangelo, Elvira Pelosi, Germana Castelli, Francesco Lo‐Coco, Ugo Testa · 2017 · Blood Cells Molecules and Diseases
  75. Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities
    Meimei Wang, Yaping Xiao, Jie Miao, Xin Zhang, Meng Liu, Longchao Zhu, Hongxin Liu, Xiaoyan Shen, Jihui Wang, Biao Xie et al. · 2025 · Antioxidants
  76. Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
    Stefano Campaner, Bruno B. Amati · 2012 · Cell Division
  77. The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading
    Anna Baulies, Joan Montero, Núria Matías, Naroa Insausti-Urkia, Oihana Terrones, Gorka Basáñez, Carmen G. Vallejo, Laura Conde de la Rosa, Laura Martínez-Gili, David Robles et al. · 2017 · Redox Biology
  78. Estimation of cancer risks and benefits associated with a potential increased consumption of fruits and vegetables
    Richard Reiss, Jason Johnston, Kevin Tucker, John M. DeSesso, Carl L. Keen · 2012 · Food and Chemical Toxicology
  79. Sirtuins and the Metabolic Hurdles in Cancer
    Natalie J. German, Marcia C. Haigis · 2015 · Current Biology
  80. Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia
    Eun‐Taex Oh, Chan Woo Kim, Ha Gyeong Kim, Jae‐Seon Lee, Heon Joo Park · 2017 · Theranostics
  81. The Antioxidant Paradox: What are Antioxidants and How Should They Be Used in a Therapeutic Context for Cancer
    Michael Yi Bonner, Jack L. Arbiser · 2014 · Future Medicinal Chemistry
  82. Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1α
    Nitin N. Patel, Caryn S. Gonsalves, Punam Malik, Vijay K. Kalra · 2008 · Blood
  83. A therapeutic role for targeting c-Myc/Hif-1- dependent signaling pathways
    Klaus Podar, Kenneth Carl Anderson · 2010 · Cell Cycle
  84. Mitochondrial Regulation of Cell Survival and Death During Low-Oxygen Conditions
    Colleen M. Snyder, Navdeep S. Chandel · 2009 · Antioxidants and Redox Signaling
  85. Oxidative Stress and Hypoxia Contribute to Alzheimer's Disease Pathogenesis: Two Sides of the Same Coin
    Michela Guglielmotto, Elena Tamagno, Oliviero Danni · 2009 · The Scientific World JOURNAL
  86. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment
    Ubaldo Martinez‐Outschoorn, Joseph Curry, Ying‐Hui Ko, Zhao Lin, Madalina Tuluc, David M. Cognetti, Ruth Birbe, Edmund A. Pribitkin, Alessandro Bombonati, Richard G. Pestell et al. · 2013 · Cell Cycle
  87. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion
    Jianjun Lei, Xiongwei Huo, Wanxing Duan, Qinhong Xu, Rong Li, Jiguang Ma, Xuqi Li, Liang Han, Wei Li, Hao Sun et al. · 2014 · Cancer Letters
  88. Clinical implications of the oncometabolite succinate in SDHx ‐mutation carriers
    Karin Eijkelenkamp, Thamara E. Osinga, Thera P. Links, Anouk N.A. van der Horst‐Schrivers · 2019 · Clinical Genetics
  89. High-Dose Vitamin C for Cancer Therapy
    Ali Mussa, Ros Akmal Mohd Idris, Naveed Ahmed, Suhana Ahmad, Ahmad Hafiz Murtadha, Tengku Ahmad Damitri Al‐Astani Tengku Din, Chan Yean Yean, Wan Faiziah Wan Abdul Rahman, Norhafiza Mat Lazim, Vuk Uskoković et al. · 2022 · Pharmaceuticals
  90. Myeloid derived suppressor cells
    Todd J. Waldron, Jon G. Quatromoni, Tatiana A. Karakasheva, Sunil Kumar Singhal, Anil K. Rustgi · 2013 · OncoImmunology
  91. Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress
    Christoph Klingelhoeffer, Ulrike Kämmerer, Monika Koospal, Bettina Mühling, Manuela Schneider, Michaela Kapp, Alexander Christian Kübler, Christoph‐Thomas Germer, Christoph Otto · 2012 · BMC Complementary and Alternative Medicine
  92. Therapeutic Manipulation of the HIF Hydroxylases
    Simon Nagel, Nick P. Talbot, Jasmin Mecinović, Thomas G. Smith, Alastair Mitchell Buchan, Christopher John Schofield · 2009 · Antioxidants and Redox Signaling
  93. Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells
    Dong Hui Shin, Usawadee Dier, Juan Andres Melendez, Nadine Hempel · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  94. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma
    Fangfang Jin, Yanbo Wang, Yanan Zhu, Shan Li, Ying Liu, Cheng Yeh Chen, Xiaohua Wang, Ke Zen, Limin Li · 2017 · Scientific Reports
  95. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor
    Ida Karin Nordgren, Ali Tavassoli · 2011 · Chemical Society Reviews
  96. Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis
    Yang Zi Jiang, Yuan Cao, Yongbin Wang, Wei Li, Xinyi Liu, Yixuan Lv, Xiaoling Li, Jun Mi · 2017 · Theranostics
  97. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting “stemness”
    Gloria Bonuccelli, Ernestina Marianna De Francesco, Rianne de Boer, Herbert Bernard Tanowitz, Michael P. Lisanti · 2017 · Oncotarget
  98. Sulfur metabolism and its contribution to malignancy
    Nathan P. Ward, Gina M. DeNicola · 2019 · International review of cytology
  99. Bioceramic Scaffolds with Antioxidative Functions for ROS Scavenging and Osteochondral Regeneration
    Cuijun Deng, Quan Zhou, Meng Zhang, Tian Li, Haotian Chen, Chang Wu Xu, Qishuai Feng, Xin Wang, Feng Yin, Yu Cheng et al. · 2022 · Advanced Science
  100. Vitamin C is dispensable for oxygen sensing in vivo
    Katarzyna J. Nytko, Nobuyo Maeda, Philipp Schläfli, Patrick Spielmann, Roland H. Wenger, Daniel P. Stiehl · 2011 · Blood